Research site · London, ON

London East Medical Centre

One of our physician-led research sites in London, running clinical studies with local volunteers since 1997.

295 Saskatoon St., London, ON, N5W 6A2(519) 659-4040Monday - Thursday: 9am - 5pmFriday: 9am - 3pm

1 study is enrolling here now
Since 1997Conducting research
170+Studies completed
2Clinical investigators
  • Physician-led: two clinical investigators on site
  • Every study is reviewed by a research ethics board before it opens
  • Run under Health Canada regulations and ICH Good Clinical Practice
  • What you submit goes only to this site’s research team

About this research site

Dr. Peter Dzongowski and his professional team at Milestone Research have been offering clinical trials to London area patients since 1997. In addition to his busy family practice and research office, Dr. Dzongowski is a certified pilot and aviation enthusiast; he also enjoys skiing and sailing in his spare time. The research office is open Monday to Thursday from 9am to 5pm and Friday from 9am to 3pm. If you are interested in a study but cannot make it in during regular business hours, ask the research team about arranging an after-hours appointment.

The people who would look after you

The investigators below are responsible for the studies run at this site, supported by the research team who coordinate your visits. These are the people you would meet.

PD
Dr. Peter DzongowskiMD
Family physician and clinical investigator

Family physician since 1993 and a graduate of Western University's Schulich School of Medicine and Dentistry, with privileges at St. Joseph's Health Care London and London Health Sciences Centre. Has taken part, as a study doctor, in large international trials of diabetes, heart, weight-loss and vaccine treatments.

LS
Dr. Leslie SinclairMD
Sub-investigator

Family physician and a graduate of Western University's Schulich School of Medicine and Dentistry, certified in family medicine since 2014. Works alongside Dr. Dzongowski on the studies running at this site, sharing responsibility for participant care and study visits.

Research nurses and coordinators
  • TaraSenior clinical research coordinator
  • AndreaClinical research coordinator
  • MichelleClinical research nurse
  • MariaClinical research coordinator
Visiting

Getting here, and what a first visit looks like

Address295 Saskatoon St., London, ON, N5W 6A2
HoursMonday - Thursday: 9am - 5pm
Friday: 9am - 3pm
If you are interested in a study but cannot come in during regular business hours, ask the coordinator about arranging an after-hours appointment.
The map loads from Google only if you ask for it.
Open directions
What happens on a first visit
  1. 1A phone call firstA coordinator calls to go through your health history and answer your questions. Nothing is booked until you want it to be.
  2. 2Informed consentThe team walks through the study in plain language, including what is being tested and the known risks.
  3. 3Screening checksSimple tests confirm whether the study is a fit. Being screened does not commit you to taking part.
  4. 4Your decisionYou choose whether to continue, and you can stop at any point without affecting your regular care.

Inside the clinic

6 photos, scroll for more
Track record

What this site has done

170+Studies completed
2,200+Volunteers
15Therapeutic areas
45+Approved medicines studied
1Enrolling right now
Figures from our study records, updated October 2026.
History

How research started here

  1. 1997Research begins in LondonDr. Dzongowski began leading clinical trials for London-area patients in 1997, alongside his family practice. The research office now trades as Milestone Research.
  2. Today1 study enrolling in LondonAcross 15 areas of medicine.
Publications and recognition

Published research and recognition

Peer-reviewed publications and public recognition involving this site’s investigators. Each link opens the original source on another website.

  1. 2025
    Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 DiabetesNew England Journal of Medicine. 2025;393(24):2409-2420 · Lead author: Stephen J. Nicholls, for the SURPASS-CVOT Investigators

    Results of SURPASS-CVOT, a trial of more than 13,000 people with type 2 diabetes and heart or blood vessel disease. Tirzepatide protected the heart at least as well as dulaglutide, an established diabetes medicine: heart attack, stroke or death from heart disease occurred in 12.2% vs 13.1% of people. Dr. Dzongowski was one of the trial's investigators.

    Read the source (opens in a new tab)
  2. 2025
    Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical TrialJAMA. 2025;334(1):46-55 · Lead author: Akshay S. Desai, for the KARDIA-2 Study Group

    Results of KARDIA-2, a trial of 663 adults whose blood pressure was not controlled by one standard medicine. Adding a single injection of zilebesiran lowered 24-hour systolic blood pressure by a further 4.5 to 12 mm Hg, depending on the medicine it was added to. Some side effects, such as high potassium and low blood pressure, were more common but mostly mild. Dr. Dzongowski and Dr. Sinclair were among the trial's investigators.

    Read the source (opens in a new tab)
  3. 2023
    Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older AdultsNew England Journal of Medicine. 2023;388(7):595-608 · Lead author: Alberto Papi, for the AReSVi-006 Study Group

    Results of a trial of 24,966 adults aged 60 or older. One dose of an RSV vaccine was about 83% effective at preventing RSV lung infections, and about 94% effective against severe cases, over about 7 months. Dr. Dzongowski was one of the trial's investigators.

    Read the source (opens in a new tab)
  4. 2022
    Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trialTranslational Psychiatry. 2022;12:101 · Lead author: Arun K. Tiwari

    A Canadian trial testing whether a genetic test, which shows how a person's body processes antidepressants, can help doctors choose depression treatment. The improvements seen were in line with a larger US trial, and the authors concluded the test can be a useful tool for guiding depression treatment in Canada. Dr. Dzongowski is one of the paper's authors.

    Read the source (opens in a new tab)
  5. 2016
    Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy studyJournal of Clinical Pharmacy and Therapeutics. 2016;41(6):695-702 · Lead author: S. E. Kjeldsen

    A one-year international study of a single pill combining two blood pressure medicines, nifedipine and candesartan, in people with moderate to severe high blood pressure. The pill was generally well tolerated and lowered blood pressure by about 30/13 mm Hg on average. Dr. Dzongowski is one of the paper's authors.

    Read the source (opens in a new tab)
Contribution to medicine

Research here becomes medicine everywhere

Clinical studies are funded by the companies developing the treatment being tested. The companies below have sponsored research at this site, and many of them have gone on to bring new medicines to Canadians. A name here does not mean one of their studies is enrolling right now, and it is not an endorsement of any product.

Studies at this site have been sponsored by
  • GSK
  • Novo Nordisk
  • Pfizer
  • Amgen
  • Boehringer Ingelheim
  • AstraZeneca
  • Merck
  • Lilly
  • Sanofi
  • Moderna
  • Novartis
  • Bayer
  • Daiichi Sankyo
  • Alnylam Pharmaceuticals
  • Antibe
  • Bristol Myers Squibb
  • Cubist Pharmaceuticals
  • Esperion
  • Regeneron
  • Searle
  • Takeda
  • Abbott
  • Altana
  • Astellas
  • Aventis
  • Biohaven Pharmaceuticals
  • Circassia
  • DS Biopharma
  • Ferring
  • Genentech
  • Inversago Pharma
  • Marea Therapeutics
  • Marealis
  • Medicago
  • MedImmune
  • Organon
  • Otsuka Pharmaceutical
  • Paradigm Biopharmaceuticals
  • Pharmacia
  • PPD
  • Purdue
  • Servier
  • Wyeth

Acasti, Assurex Health, Avillion, Carbylan, Dimethaid, Furiex Pharmaceuticals, IDB, Intarcia, Janssen, Labopharm, Metabolex, Phenomix, Trial Management Group Inc., Viveve

Medicines now approved in Canada that were studied at this site

  • Forxiga
  • Lantus / Toujeo
  • Ozempic / Wegovy / Rybelsus
  • Awiqli
  • Onglyza
  • Trajenta
  • Tresiba

  • Arexvy
  • Prevnar 20
  • Tamiflu
  • Capvaxive
  • Trumenba
  • Vaxneuvance

  • Pradaxa
  • Edarbyclor
  • Twynsta
  • Verapamil

  • Celebrex
  • Prolia
  • Butrans
  • Febuxostat
  • Pennsaid
  • Pentosan polysulfate
  • Tridural / Zytram XL

  • Mounjaro / Zepbound

  • Repatha
  • Nilemdo

  • Advair
  • Dupixent
  • Trelegy
  • Alvesco
  • Anoro
  • Arnuity
  • Breo
  • Grastek
  • Ultibro

  • Aricept
  • Imitrex
  • Nurtec ODT
  • Relpax

  • Rexulti

  • Viberzi

  • DDAVP

  • Eucrisa

  • Varenicline

  • Veozah

A medicine is listed because it was part of at least one study at this site. This is not a recommendation: only your own doctor can say whether a medicine is right for you.

Questions about this site

Do I need a referral from my family doctor?
No. You can contact the site directly. With your permission the research team will keep your family doctor informed, which is standard practice in clinical research.
I am not a patient at this clinic. Can I still take part?
Yes. The site works with volunteers from across the London area, alongside local family doctors, specialists and nurse practitioners.
Will taking part cost me anything?
No. Study visits and study-related assessments are provided at no cost, and reasonable travel costs may be reimbursed where a study allows it.
How far will I have to travel?
Visits for the studies listed here take place at 295 Saskatoon St., London, ON, N5W 6A2. The coordinator confirms the full visit schedule with you before you agree to anything.
What happens to the information I submit?
It goes to this site’s research team so they can contact you about studies. It is not sold, and you can ask to be removed from their records at any time.
Request contact

Ask London East Medical Centre to contact you

Your answers go to our research team and this research site, so the team can prepare before they call. Completing the form does not obligate you to take part, and you can always call them directly on (519) 659-4040.

Phone(519) 659-4040

  • Physician-led: two clinical investigators on site
  • Every study is reviewed by a research ethics board before it opens
  • Run under Health Canada regulations and ICH Good Clinical Practice
  • What you submit goes only to this site’s research team
Study interest form

See if you may qualify

A few quick questions — about a minute. Your answers help the research team prepare before they contact you.

For anyone under 18, a parent or legal guardian should complete this form and would need to consent on their behalf.

Ask this site to contact you